论文部分内容阅读
目的:探讨沙美特罗替卡松干粉吸入剂联合噻托溴铵治疗稳定期慢性阻塞性肺疾病(COPD)的疗效。方法:将2012年10月-2014年7月我科诊治的稳定期COPD患者100例随机分为对照组和观察组各50例,对照组给予噻托溴铵治疗,观察组在此基础上联合沙美特罗替卡松干粉吸入剂治疗,比较两组的疗效。结果:观察组的肺功能指标明显优于对照组(P<0.05),观察组的临床症状与日常生活评分均明显优于治疗前和对照组治疗后(P<0.05)。结论:在稳定期COPD临床治疗方案中,沙美特罗替卡松干粉吸入剂联合噻托溴铵治疗的疗效确切,可明显改善患者肺部功能,建议推广使用。
Objective: To investigate the efficacy of salmeterol and ticagrelor dry powder inhalation combined with tiotropium in the treatment of stable chronic obstructive pulmonary disease (COPD). Methods: 100 patients with stable COPD who were diagnosed and treated in our department from October 2012 to July 2014 were randomly divided into control group and observation group (50 cases each), the control group was treated with tiotropium, the observation group was united on this basis Salmeterol fluticasone dry powder inhalation therapy, the efficacy of the two groups were compared. Results: The indexes of pulmonary function in the observation group were significantly better than those in the control group (P <0.05). The clinical symptoms and daily life scores of the observation group were significantly better than those before treatment and the control group after treatment (P <0.05). Conclusion: In the clinical treatment of stable COPD program, salmeterol ticagrelor dry powder inhalation combined with tiotropium treatment of the exact effect, can significantly improve the patient’s lung function, it is recommended to promote the use of.